KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 204 filers reported holding KURA ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $63,000 | -95.9% | 2,218 | -94.6% | 0.00% | -100.0% |
| Q4 2020 | $1,536,000 | +15.9% | 41,188 | -3.2% | 0.00% | 0.0% |
| Q3 2020 | $1,325,000 | +105.1% | 42,534 | +17.8% | 0.00% | 0.0% |
| Q2 2020 | $646,000 | +864.2% | 36,118 | +646.5% | 0.00% | – |
| Q4 2019 | $67,000 | +45.7% | 4,838 | +60.7% | 0.00% | – |
| Q3 2019 | $46,000 | -6.1% | 3,010 | +22.1% | 0.00% | – |
| Q2 2019 | $49,000 | – | 2,465 | +82066.7% | 0.00% | – |
| Q1 2019 | $0 | -100.0% | 3 | -99.2% | 0.00% | – |
| Q4 2018 | $6,000 | +100.0% | 400 | +105.1% | 0.00% | – |
| Q3 2018 | $3,000 | 0.0% | 195 | +10.8% | 0.00% | – |
| Q2 2018 | $3,000 | -97.9% | 176 | -97.7% | 0.00% | – |
| Q1 2018 | $144,000 | -4.0% | 7,636 | -22.4% | 0.00% | – |
| Q4 2017 | $150,000 | -97.5% | 9,834 | -97.6% | 0.00% | -100.0% |
| Q3 2017 | $6,018,000 | – | 402,434 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |